SE437470B - Forfarande for utvinning av ett rent gammaglobulinpreparat, som tolereras vid intravenos administrering - Google Patents

Forfarande for utvinning av ett rent gammaglobulinpreparat, som tolereras vid intravenos administrering

Info

Publication number
SE437470B
SE437470B SE7514388A SE7514388A SE437470B SE 437470 B SE437470 B SE 437470B SE 7514388 A SE7514388 A SE 7514388A SE 7514388 A SE7514388 A SE 7514388A SE 437470 B SE437470 B SE 437470B
Authority
SE
Sweden
Prior art keywords
tolered
intravenos
gammaglobulin
administration
recovery
Prior art date
Application number
SE7514388A
Other languages
English (en)
Swedish (sv)
Other versions
SE7514388L (sv
Inventor
W Schneider
D Wolter
Original Assignee
Armour Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armour Pharma filed Critical Armour Pharma
Publication of SE7514388L publication Critical patent/SE7514388L/
Publication of SE437470B publication Critical patent/SE437470B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
SE7514388A 1975-01-02 1975-12-18 Forfarande for utvinning av ett rent gammaglobulinpreparat, som tolereras vid intravenos administrering SE437470B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2500076A DE2500076C3 (de) 1975-01-02 1975-01-02 Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen

Publications (2)

Publication Number Publication Date
SE7514388L SE7514388L (sv) 1976-07-05
SE437470B true SE437470B (sv) 1985-03-04

Family

ID=5935911

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7514388A SE437470B (sv) 1975-01-02 1975-12-18 Forfarande for utvinning av ett rent gammaglobulinpreparat, som tolereras vid intravenos administrering

Country Status (20)

Country Link
JP (1) JPS5512001B2 (enrdf_load_stackoverflow)
AT (1) AT344883B (enrdf_load_stackoverflow)
AU (1) AU505416B2 (enrdf_load_stackoverflow)
BE (1) BE837211A (enrdf_load_stackoverflow)
CA (1) CA1058075A (enrdf_load_stackoverflow)
DD (1) DD121875A5 (enrdf_load_stackoverflow)
DE (1) DE2500076C3 (enrdf_load_stackoverflow)
DK (1) DK144679C (enrdf_load_stackoverflow)
EG (1) EG11987A (enrdf_load_stackoverflow)
ES (1) ES443982A1 (enrdf_load_stackoverflow)
FR (1) FR2296429A1 (enrdf_load_stackoverflow)
GB (1) GB1495159A (enrdf_load_stackoverflow)
IE (1) IE43449B1 (enrdf_load_stackoverflow)
IL (1) IL48766A (enrdf_load_stackoverflow)
IN (1) IN143525B (enrdf_load_stackoverflow)
NL (1) NL179824C (enrdf_load_stackoverflow)
PL (1) PL99599B1 (enrdf_load_stackoverflow)
SE (1) SE437470B (enrdf_load_stackoverflow)
SU (1) SU576898A3 (enrdf_load_stackoverflow)
ZA (1) ZA758050B (enrdf_load_stackoverflow)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2604759C2 (de) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von iv-verträglichen Γglobulinen
JPS6016406B2 (ja) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
GB1603244A (en) * 1977-05-20 1981-11-18 Max Planck Gesellschaft Medicaments for the suppression of pathological processes
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
EP0019403B1 (en) * 1979-05-10 1985-07-31 American Hospital Supply Corporation Hydroxyalkyl-starch drug carrier
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
ATE19735T1 (de) * 1982-02-08 1986-05-15 Schweiz Serum & Impfinst Intravenoes verabreichbares humanes immunglobulin und verfahren zu dessen herstellung.
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
SE8302483L (sv) * 1983-05-02 1984-11-03 Pharmacia Ind Forfarande vid rening av biologiskt aktiva substanser
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
DE19907257A1 (de) * 1999-02-21 2000-09-14 Bernd Horst Meier Mittel zur Steuerung der Diffusion von Injektionslösungen
DE10040707A1 (de) * 2000-08-17 2002-03-14 Braun Melsungen Ag Kolloidale Pharmakomodulation injizierter Arzneimittel
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
DK1954718T3 (en) 2005-11-30 2014-12-15 Abbvie Inc Anti-A-globulomer antibodies antigenbindingsgrupper thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods for producing said antibodies,
KR20180058863A (ko) 2005-11-30 2018-06-01 애브비 인코포레이티드 아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US8895004B2 (en) 2007-02-27 2014-11-25 AbbVie Deutschland GmbH & Co. KG Method for the treatment of amyloidoses
MX360403B (es) 2010-04-15 2018-10-31 Abbvie Inc Proteinas de union a amiloide beta.
MX358739B (es) 2010-08-14 2018-09-03 Abbvie Inc Star Proteinas de union a amiloide beta.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE348942B (enrdf_load_stackoverflow) * 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
DE2234069A1 (de) * 1971-07-16 1973-02-08 South African Inventions Verfahren zur herstellung eines gereinigten gamma-globulins
ZA738779B (en) * 1972-11-27 1974-10-30 Baxter Laboratories Inc Production of gamma globulin
JPS49101516A (enrdf_load_stackoverflow) * 1973-01-13 1974-09-25

Also Published As

Publication number Publication date
DK144679B (da) 1982-05-10
GB1495159A (en) 1977-12-14
DK144679C (da) 1982-10-11
FR2296429A1 (fr) 1976-07-30
FR2296429B1 (enrdf_load_stackoverflow) 1978-12-01
BE837211A (fr) 1976-06-30
AU505416B2 (en) 1979-11-22
NL179824C (nl) 1986-11-17
IN143525B (enrdf_load_stackoverflow) 1977-12-17
ES443982A1 (es) 1977-07-16
PL99599B1 (pl) 1978-07-31
NL7514627A (nl) 1976-07-06
IE43449L (en) 1976-07-02
SE7514388L (sv) 1976-07-05
NL179824B (nl) 1986-06-16
DE2500076B2 (de) 1979-02-22
IE43449B1 (en) 1981-02-25
EG11987A (en) 1981-12-31
JPS5191321A (en) 1976-08-10
JPS5512001B2 (en) 1980-03-29
ZA758050B (en) 1976-12-29
AT344883B (de) 1978-08-10
AU8792175A (en) 1977-07-14
CA1058075A (en) 1979-07-10
IL48766A0 (en) 1976-02-29
ATA981675A (de) 1977-12-15
DD121875A5 (enrdf_load_stackoverflow) 1976-09-05
DE2500076A1 (de) 1976-07-08
DK584375A (da) 1976-07-03
SU576898A3 (ru) 1977-10-15
IL48766A (en) 1979-11-30
DE2500076C3 (de) 1982-11-18

Similar Documents

Publication Publication Date Title
SE437470B (sv) Forfarande for utvinning av ett rent gammaglobulinpreparat, som tolereras vid intravenos administrering
SE434394B (sv) Analogiforfarande for framstellning av kinolonalkansyraderivat
NO142172C (no) Analogifremgangsmaate for fremstilling av som antikonvulsiva virksomme alfa-fenyl-benzyliden-aminosyrederivater
DK162391C (da) Analogifremgangsmaade til fremstilling af syn-isomerer af 3,7-disubstituerede 3-cephem-4-carboxylsyreforbindelser
SE431456B (sv) Analogiforfarande for framstellning av kondenserade kinazolonderivat
DK562276A (da) Fremgangsmaade til fremstilling af en farmaceutisk administrationsform
DK143708C (da) Analogifremgangsmaade til fremstilling af 17alfa-acyloxy-9alfa,21-dihalogen-11beta-hydroxy-6alfa-fluor-16alfa-methyl-pregna-1,4-dien-3,20-dion-forbindelser
DK145228C (da) Analogifremgangsmaade til fremstilling af 3-amino-4-deoxo-4-iminorifamycinderivater
DK286777A (da) Fremgangsmade til fremstilling af penicillansyrederivater
DK150144C (da) Fremgangsmaade til fremstilling af tetracykliske, kondenserede pyrazinderivater
DK143899C (da) Analogifremgangsmaade til fremstilling af piperazinylpyrazinderivater
DK143339C (da) Analogifremgangsmaade til fremstilling af 6-oxo-7,7-disubstitueret-1,2,7,8-tetrahydro-6h-indeno(5,4-b)furan-2-carboxylsyrer
DK148744C (da) Analogifremgangsmaade til fremstilling af den enkelte isomere eller en isomerblanding af spiro-(1,3-dioxolan-4,3') quinuclidiner eller farmaceutisk acceptable syreadditionssalte deraf
DK431176A (da) Fremgangsmade til fremstilling af hypolipemiske phenyleddikesyrederivater
DK153489C (da) Analogifremgangsmaade til fremstilling af 7-aminothiazolylacetamidocephalosporansyrederivater
DK150478C (da) Analogifremgangsmaade til fremstilling af n-aryl-n-(4-piperidyl)-arylacetamidderivater
DK150484C (da) Analogifremgangsmaade til fremstilling af 4-amino-3-thiophencarboxylsyrederivater
DK154888C (da) Analogifremgangsmaade til fremstilling af 6-substituerede-6-methoxypenicillansyrederivater
DK157401C (da) Analogifremgangsmaade til fremstilling af substituerede n-methylenderivater af thienamycin
SE7605751L (sv) Forfarande for framstellning av en bensotiazinforening
DK143905C (da) Analogifremgangsmaade til fremstilling af fusidinsyrederivater
DK377976A (da) Fremgangsmade til reduktion af en zeralenonforbindelse til enzearalenolforbindelse
DK475376A (da) Fremgangsmade til fremstilling af 2,9-dioxatricyclo/4,3,1,03,7/decan-forbindelser
SE441092B (sv) Forfarande for separation av c?717-c?7130-alkansulfonsyror fran en sulfoneringslosning
SE7605054L (sv) Forfarande vid forpackning av garnspolar

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7514388-3

Effective date: 19891128

Format of ref document f/p: F